Search Results - Alessio Provenzani
- Showing 1 - 8 results of 8
-
1
-
2
-
3
Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: a systematic review by Giulia Matranga, Anna Carollo, Miriam Alaimo, Sofia Cutaia, Sergio Rizzo, Alessio Provenzani
Published in Therapeutic Advances in Drug Safety (2025-08-01)Get full text
Article -
4
-
5
-
6
Efficacy and Safety of Remdesivir in Adult Solid Organ Transplant Recipients: A Scoping Review by Catherine Smith, Maria Eugenia Novara, Andrea Cona, Anna Dolcimascolo, Giulia Cancellieri, Francesca Mortillaro, Enrico Ottavio Giannini, Anna Carollo, Alessandra Mularoni, Alessio Provenzani
Published in Pharmaceuticals (2024-06-01)Get full text
Article -
7
Real-world insights into safety, tolerability, and predictive factors of adverse drug reactions in treating idiopathic pulmonary fibrosis with pirfenidone and nintedanib by Alessio Provenzani, Daniele Leonardi Vinci, Miriam Alaimo, Salvatore Di Maria, Fabio Tuzzolino, Gaetano Floridia, Roberta Di Stefano, Anna Carollo, Adriana Callari, Piera Polidori, Patrizio Vitulo
Published in Therapeutic Advances in Drug Safety (2025-05-01)Get full text
Article -
8
Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience by Andrea Cona, Alessandro Tavelli, Stefano Agrenzano, Neha Hafeez, Giovanni Scianna, Angelo Maria, Francesco Marino, Elizabeth De La Cruz, Maria Di Giorgio, Eglys Osorio, Giuseppe Cucinella, Angelo Luca, Alessio Provenzani, Patrizio Vitulo, Alessandro Bertani, Paolo Antonio Grossi, Alessandra Mularoni
Published in Microorganisms (2024-07-01)Get full text
Article
